Physician Profile

Mark S. Fradin, M.D.

Unclaimed Profile

About Dr. Fradin

Mark S. Fradin, M.D. practices dermatology in Chapel Hill, NC. Mark is a 1986 graduate of Columbia University College of Physicians and Surgeons. Medicare claims data shows Mark provided 4,132 services to 2,161 patients.

Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it.

Specialty

Dermatology (Primary)

Credentials & Licensing

NC license39263
NPI1306809157
NPI issued04/11/2006

Source: NPPES NPI Registry

Common questions

What does Mark S. Fradin specialize in?

Mark S. Fradin is a dermatologist (skin doctor) in Chapel Hill, NC. That is the designation recorded for this NPI in the federal registry, where it is listed as “Dermatology”.

NPI registry

Where is Mark S. Fradin located?

Mark S. Fradin is listed at 891 Willow Dr Suite 1, Chapel Hill, NC 27514. Addresses come from the NPI registry and can lag a move, so confirm before travelling.

NPI registry

What is Mark S. Fradin's phone number?

The number on file is (919) 942-3106. Guide.md cannot book appointments or pass on messages — please call the office directly.

NPI registry

What is the NPI for Mark S. Fradin?

Mark S. Fradin's National Provider Identifier is 1306809157. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.

NPI registry

Where did Mark S. Fradin train?

Mark S. Fradin attended Columbia University College of Physicians and Surgeons, graduating in 1986. This comes from the CMS National Downloadable File.

CMS public data

How much experience does Mark S. Fradin have?

Mark S. Fradin has 40 years experience. Calculated from a graduation year of 1986, reported in the CMS National Downloadable File.

CMS public data

What does Mark S. Fradin do most often?

According to Medicare billing data, Mark S. Fradin performs procedures including destruction of precancer skin growth, 2-14 growths, destruction of precancer skin growth, 1 growth and biopsy of related skin growth, first growth, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.

Medicare claims

Is Mark S. Fradin's profile verified?

Not yet. This profile is built from public federal data and has not been confirmed by Mark S. Fradin. If this is you, claiming it is free.

Guide.md

Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.